I would think that it is too early to tell.
The Medify side would, right now, probably bring down the value.....by Q3, i would think that would have changed significantly, presuming the 15c211 gets done. Also, there should be more rollouts with TPP and SystemOne, with REAL revenues coming in and, hopefully, EMIS will get its head out of its (pearly) a$$ and let MedifyRemote get up and flying.
Then, there will be two independent revenue streams with great upside potential. Plus, the adult side would be that much closer to meeting or exceeding its '07 projections, which would certainly increase the overall value, since all of the revenue streams would be on the upswing, as opposed to other more established companies where growth is slower.
